1. Home
  2. APRE vs GFAI Comparison

APRE vs GFAI Comparison

Compare APRE & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • GFAI
  • Stock Information
  • Founded
  • APRE 2006
  • GFAI 2018
  • Country
  • APRE United States
  • GFAI Singapore
  • Employees
  • APRE N/A
  • GFAI N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • GFAI Diversified Commercial Services
  • Sector
  • APRE Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • APRE Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • APRE 15.8M
  • GFAI 18.2M
  • IPO Year
  • APRE 2019
  • GFAI N/A
  • Fundamental
  • Price
  • APRE $4.08
  • GFAI $2.07
  • Analyst Decision
  • APRE Strong Buy
  • GFAI Strong Buy
  • Analyst Count
  • APRE 2
  • GFAI 2
  • Target Price
  • APRE $15.50
  • GFAI $6.75
  • AVG Volume (30 Days)
  • APRE 33.0K
  • GFAI 7.2M
  • Earning Date
  • APRE 11-07-2024
  • GFAI 01-01-0001
  • Dividend Yield
  • APRE N/A
  • GFAI N/A
  • EPS Growth
  • APRE N/A
  • GFAI N/A
  • EPS
  • APRE N/A
  • GFAI N/A
  • Revenue
  • APRE $1,310,839.00
  • GFAI $35,841,743.00
  • Revenue This Year
  • APRE $134.21
  • GFAI $0.37
  • Revenue Next Year
  • APRE N/A
  • GFAI $5.60
  • P/E Ratio
  • APRE N/A
  • GFAI N/A
  • Revenue Growth
  • APRE 130.31
  • GFAI 1.78
  • 52 Week Low
  • APRE $2.15
  • GFAI $0.94
  • 52 Week High
  • APRE $8.85
  • GFAI $4.30
  • Technical
  • Relative Strength Index (RSI)
  • APRE 62.50
  • GFAI 52.50
  • Support Level
  • APRE $3.34
  • GFAI $1.84
  • Resistance Level
  • APRE $4.41
  • GFAI $2.12
  • Average True Range (ATR)
  • APRE 0.43
  • GFAI 0.48
  • MACD
  • APRE 0.04
  • GFAI -0.02
  • Stochastic Oscillator
  • APRE 54.19
  • GFAI 20.72

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.

Share on Social Networks: